Log In
Print
BCIQ
Print
Print this Print this
 

imetelstat (GRN163L)

  Manage Alerts
Collapse Summary General Information
Company Geron Corp.
DescriptionOligonucleotide that competitively inhibits telomerase activity
Molecular Target Telomerase
Mechanism of ActionTelomerase inhibitor
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationMyeloproliferative disorder
Indication DetailsTreat essential thrombocythemia (ET) or polycythemia vera (PV); Treat myelofibrosis (MF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today